Virtual Clinical Trials Market Growth Opportunities and Forecast till 2030
CHAPTER 1. Industry Overview of Virtual Clinical Trials Market
1.1. Definition and Scope
1.1.1. Definition of Virtual Clinical Trials
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Virtual Clinical Trials Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Virtual Clinical Trials Market By Study Design
1.2.3. Virtual Clinical Trials Market By Indication
1.2.4. Virtual Clinical Trials Market By Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Powder Sources
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Virtual Clinical Trials Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Virtual Clinical Trials Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Virtual Clinical Trials Market By Study Design
4.1. Introduction
4.2. Virtual Clinical Trials Market Revenue (US$ Mn) By Study Design
4.2.1. Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
4.2.2. Interventional
4.2.2.1. Interventional Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
4.2.3. Observational
4.2.3.1. Observational Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
4.2.4. Expanded Access
4.2.4.1. Expanded Access Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 5. Virtual Clinical Trials Market By Indication
5.1. Introduction
5.2. Virtual Clinical Trials Market Revenue (US$ Mn) By Indication
5.2.1. Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
5.2.2. Oncology
5.2.2.1. Oncology Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.3. Cardiovascular
5.2.3.1. Cardiovascular Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.4. Others
5.2.4.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 6. North America Virtual Clinical Trials Market By Country
6.1. North America Virtual Clinical Trials Market Overview
6.2. U.S.
6.2.1. U.S. Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
6.2.2. U.S. Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
6.3. Canada
6.3.1. Canada Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
6.3.2. Canada. Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
6.4. North America PEST Analysis
CHAPTER 7. Europe Virtual Clinical Trials Market By Country
7.1. Europe Virtual Clinical Trials Market Overview
7.2. U.K.
7.2.1. U.K. Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
7.2.2. U.K. Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
7.3. Germany
7.3.1. Germany Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
7.3.2. Germany Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
7.4. France
7.4.1. France Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
7.4.2. France Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
7.5. Spain
7.5.1. Spain Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
7.5.2. Spain Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
7.6. Rest of Europe
7.6.1. Rest of Europe Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
7.6.2. Rest of Europe Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
7.7. Europe PEST Analysis
CHAPTER 8. Asia Pacific Virtual Clinical Trials Market By Country
8.1. Asia Pacific Virtual Clinical Trials Market Overview
8.2. China
8.2.1. China Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
8.2.2. China Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
8.3. Japan
8.3.1. Japan Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
8.3.2. Japan Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
8.4. India
8.4.1. India Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
8.4.2. India Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
8.5. Australia
8.5.1. Australia Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
8.5.2. Australia Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
8.6. South Korea
8.6.1. South Korea Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
8.6.2. South Korea Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
8.7. Rest of Asia-Pacific
8.7.1. Rest of Asia-Pacific Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
8.7.2. Rest of Asia-Pacific Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
8.8. Asia Pacific PEST Analysis
CHAPTER 9. Latin America Virtual Clinical Trials Market By Country
9.1. Latin America Virtual Clinical Trials Market Overview
9.2. Brazil
9.2.1. Brazil Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
9.2.2. Brazil Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
9.3. Mexico
9.3.1. Mexico Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
9.3.2. Mexico Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
9.4. Rest of Latin America
9.4.1. Rest of Latin America Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
9.4.2. Rest of Latin America Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
9.5. Latin America PEST Analysis
CHAPTER 10. Middle East & Africa Virtual Clinical Trials Market By Country
10.1. Middle East & Africa Virtual Clinical Trials Market Overview
10.2. GCC
10.2.1. GCC Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
10.2.2. GCC Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
10.3. South Africa
10.3.1. South Africa Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
10.3.2. South Africa Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
10.4. Rest of Middle East & Africa
10.4.1. Rest of Middle East & Africa Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2018-2030
10.4.2. Rest of Middle East & Africa Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2018-2030
10.5. Middle East & Africa PEST Analysis
CHAPTER 11. Player Analysis Of Virtual Clinical Trials Market
11.1. Virtual Clinical Trials Company Share Analysis
11.2. Competition Matrix
11.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
11.2.2. New Product Launches and Product Enhancements
11.2.3. Mergers And Acquisition In Global Virtual Clinical Trials market
11.2.4. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements
CHAPTER 12. Company Profile
12.1. ICON plc
12.1.1. Company Snapshot
12.1.2. Business Overview
12.1.3. Financial Overview
12.1.3.1. Revenue (US$ Mn), 2021
12.1.3.2. ICON plc Headset 2021 Virtual Clinical Trials Business Regional Distribution
12.1.4. Product/ Service Specification
12.1.5. Recent Developments & Business Strategy
12.1.6. Manufacturing Plant Footprint Analysis
12.2. Parexel International
12.3. IQVIA
12.4. Covance Inc.
12.5. PRA Health Sciences
12.6. LEO Innovation Lab
12.7. Medidata Solutions
12.8. Oracle Corporation
12.9. CRF Health
12.10. Clinical Ink, Inc.
12.11. Medable, Inc.